Effects of therapy in X-linked hypophosphatemic rickets.

Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.

Intestinal phosphate transport in familial hypophosphatemic rickets.

Hypophosphatemic rickets and its dental significance.

Hypophosphatemic rickets: etiology, clinical features and treatment.

Hypophosphatemic rickets associated with giant hairy nevus.

Hypophosphatemic rickets and its dental significance.

Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.

Nutritional hypophosphatemic rickets in a premature infant fed breast milk.

Hypophosphatemic Rickets in Siblings: A Rare Case Report.

Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.

Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Multilocus mapping of the X-linked hypophosphatemic rickets gene.

Epidermal nevus syndrome with hypophosphatemic rickets in a young girl.

Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.

Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.

Fanconi-Bickel Syndrome: Two Pakistani Patients Presenting with Hypophosphatemic Rickets.

Hypophosphatemic rickets and craniosynostosis: a multicenter case series.

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.

X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.

Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.

osteomalacia.

Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification.

Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.

Therapeutic use of oral sodium phosphate (phosribbon(®) combination granules) in hereditary hypophosphatemic rickets.

Suggest Documents

Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.

Intestinal phosphate transport in familial hypophosphatemic rickets.

Hypophosphatemic rickets and its dental significance.

Hypophosphatemic rickets: etiology, clinical features and treatment.

Hypophosphatemic rickets associated with giant hairy nevus.

Hypophosphatemic rickets and its dental significance.

Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.

Nutritional hypophosphatemic rickets in a premature infant fed breast milk.

Hypophosphatemic Rickets in Siblings: A Rare Case Report.

Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.

Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Multilocus mapping of the X-linked hypophosphatemic rickets gene.

Epidermal nevus syndrome with hypophosphatemic rickets in a young girl.

Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.

Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.

Fanconi-Bickel Syndrome: Two Pakistani Patients Presenting with Hypophosphatemic Rickets.

Hypophosphatemic rickets and craniosynostosis: a multicenter case series.

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.

X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.

Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.

osteomalacia.

Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification.

Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.

Therapeutic use of oral sodium phosphate (phosribbon(®) combination granules) in hereditary hypophosphatemic rickets.

Effects of therapy in X-linked hypophosphatemic rickets.

Recommend Documents

Follow Us